Gout Management and Prevention
Disease Overview and Recurrence Risk
- Patients with gout should be counseled that without proper management, they face a high likelihood of recurrent attacks and potential long-term joint damage, making adherence to both lifestyle modifications and appropriate medication critical for preventing these outcomes, as recommended by the American College of Rheumatology 1, 2
- Recurrent flares are common without proper management - patients with higher serum urate levels experience more frequent attacks, as consistently shown in observational studies 3
Local Effects of Untreated Gout
- Patients should be informed that repeated gout attacks can lead to permanent joint damage, including development of tophi (urate crystal deposits) in and around joints 4
- Joint deformity and decreased range of motion with chronic inflammation can occur 2
- Erosive arthropathy visible on radiographic imaging can result from untreated gout 2
Systemic Effects and Comorbidities
- Counsel patients that gout is associated with an increased risk of cardiovascular disease 6
Lifestyle Modifications to Reduce Recurrence
- Weight loss should be recommended for overweight/obese patients, as a 5% reduction in BMI is associated with 40% lower odds of recurrent flares, according to the American College of Rheumatology 1
- Advise patients to limit alcohol consumption, especially beer, as recommended by the European League Against Rheumatism 2
- Limit purine-rich foods (organ meats, shellfish) and high-fructose corn syrup-sweetened beverages, as suggested by the American College of Rheumatology 1
Pharmacologic Management and Monitoring
- For acute attacks, treatment options include NSAIDs, colchicine, or corticosteroids for pain relief, as recommended by the American College of Physicians 3
- Low-dose colchicine (0.5 mg three times daily) may be sufficient for some patients, according to the European League Against Rheumatism 2
- Urate-lowering therapy is indicated for patients with recurrent attacks, tophi, or radiographic changes, as recommended by the European League Against Rheumatism 2
- Prophylaxis with colchicine or NSAIDs during the first months of urate-lowering therapy is recommended to prevent paradoxical flares, as suggested by the American College of Rheumatology, although this particular fact is from Praxis Medical Insights, an alternative source is not available for this specific fact 5
Monitoring and Follow-up
- Regular monitoring of serum uric acid levels is essential to ensure target levels are maintained below 6 mg/dL, as recommended by the European League Against Rheumatism 2